NorthSea Therapeutics Investors

40 investors on Angel Roster list NorthSea Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the Netherlands and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name NorthSea Therapeutics can appear together.

Investors listed
40
With verified email
40%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 NorthSea Therapeutics investors

The most complete profiles first. Showing 40 of 40.

  • Alexander VosVerified

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Verified email available

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Andrew AbramsVerified

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareTelecommunicationsGeneticsCybersecurity

    Portfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • JeanVerified

    Micro VC · United States

    Health CareTelecommunicationsGeneticsCybersecurity

    Portfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Raju MohanVerified

    Micro VC · United States

    Health CareTelecommunicationsGeneticsCybersecurity

    Portfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more

    Verified email available

  • Somu SubramaniamVerified

    Micro VC · United States

    Health CareTelecommunicationsGeneticsCybersecurity

    Portfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more

    Verified email available

  • Thomas LavinVerified

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareTelecommunicationsGeneticsCybersecurity

    Portfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Diede Brunen

    Venture Capital, Private Equity Firm, Micro VC · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Edward Van Wezel

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Joost Holthuis

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Max Klement

    Venture Capital, Micro VC, Investor · United Kingdom

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Rob de Ree

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Vivek Mohindra

    Micro VC · United States

    Health CareTelecommunicationsGeneticsCybersecurity

    Portfolio: Paradigm Diagnostics, Vuv Analytics, Kateeva, Vaultive and 39 more

    Contact details available

Frequently asked questions

How many NorthSea Therapeutics investors are on Angel Roster?

Angel Roster lists 40 NorthSea Therapeutics investors. 16 of them (40%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (35), Private Equity Firms (14) and Micro VC Firms (12). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do NorthSea Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (17), Pre-Seed (6) and Series B (5).

Where are NorthSea Therapeutics investors based?

Most are based in the United States (18), the Netherlands (17) and the United Kingdom (3).

Which companies have NorthSea Therapeutics investors backed?

The most-backed portfolio companies among them are Dezima Pharma (26), Escalier Biosciences (26), Gyroscope Therapeutics (23), Promedior (23) and BioVex (20).

How do I contact NorthSea Therapeutics investors?

Create a free Angel Roster account to search and filter all 40, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.